Lose a limb or risk death? Growing numbers among Gaza’s thousands of war-wounded face hard decisions

Lose a limb or risk death? Growing numbers among Gaza’s thousands of war-wounded face hard decisions

DEIR AL-BALAH, Gaza Strip — The doctors gave Shaimaa Nabahin an impossible choice: lose your left leg or risk death. The 22-year-old had been hospitalized in Gaza for around a week, after her ankle was partially severed in an Israeli airstrike, when doctors told her she was suffering from blood poisoning. Nabahin chose to maximize … Read more

Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes

Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes

A 0.25 mg injection pen of Novo Nordisk’s weight loss drug Wegovy is shown in this photo in Oslo, Norway, on Aug. 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” drugs claiming to contain semaglutide, the active ingredient … Read more

Dysphagia red flag sign of killer cancer that can appear when eating

Dysphagia red flag sign of killer cancer that can appear when eating

Oesophageal cancer is one of more than 200 types of cancer that can affect the human body. In the UK it is the 14th most common form of the disease. However, it is the seventh most deadly, accounting for around 8,000 deaths every year – or 22 a day. Therefore, it is vital that you … Read more

DeSantis spread false information while pushing trans health care ban and restrictions, a judge says

DeSantis spread false information while pushing trans health care ban and restrictions, a judge says

TALLAHASSEE, Fla. — A federal judge hearing a challenge to a transgender health care ban for minors and restrictions for adults noted Thursday that Republican Florida Gov. Ron DeSantis repeatedly spread false information about doctors mutilating children’s genitals even though there’s been no such documented cases. The law was sold as defending children from mutilation … Read more

Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly

Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly

Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain an edge in the fast-growing obesity-treatment market. Pfizer said Friday it will discontinue its twice-daily weight-loss pill, danuglipron, after patients in a mid-stage trial experienced … Read more

‘I’m a doctor – this is the health problem that could be behind your wine headaches’

‘I’m a doctor – this is the health problem that could be behind your wine headaches’

Full-bodied, decadent red wine is a popular pairing for the Christmas dinner. While many are partial to a few glasses during the festive period, a nutritionist has revealed the reason why many may be left with a painful headache after just one glass of the red stuff. Red wine headaches can happen within 30 minutes … Read more

What I Wish I’d Known Before Chemo

What I Wish I’d Known Before Chemo

As the saying goes, “Hindsight is 20/20.” When I finished chemo in February 2011, I knew a lot more than when I walked in for my first infusion 4 months earlier. I had learned things about myself and about cancer that I had never expected to learn. Because, of course, at the beginning, I didn’t … Read more

Holiday togetherness can also mean family fights. But there are ways to try to sidestep the drama

Holiday togetherness can also mean family fights. But there are ways to try to sidestep the drama

The holidays, a time where families and friends can get together to talk, to laugh — or get into screaming arguments. There are plenty of reasons togetherness can turn into tension — maybe that cousin you mostly love has that one opinion on politics or world events you just can’t stand, or that one nosy … Read more

Pfizer to discontinue twice-daily version of weight loss pill

Pfizer to discontinue twice-daily version of weight loss pill

Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost significant weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A … Read more